Showing results (1061-1070 of 1,996) with videos related to

Sort By:
Pageof 200
The Lancet. Neurology|February 27, 2022
Safety and efficacy of three enteral feeding strategies in patients with severe stroke in China (OPENS): a multicentre, prospective, randomised, open-label, blinded-endpoint trialJingjing Zhao, Fang Yuan, Changgeng Song, et al.
The Lancet. Neurology|November 17, 2023
Clinical descriptors of disease trajectories in patients with traumatic brain injury in the intensive care unit (CENTER-TBI): a multicentre observational cohort studyCecilia A I Åkerlund, Anders Holst, Shubhayu Bhattacharyay, et al.
The Lancet. Neurology|August 31, 2023
The Neurological Pupil index for outcome prognostication in people with acute brain injury (ORANGE): a prospective, observational, multicentre cohort studyMauro Oddo, Fabio S Taccone, Matteo Petrosino, et al.
The Lancet. Neurology|August 26, 2023
Identification of genetic risk loci and causal insights associated with Parkinson's disease in African and African admixed populations: a genome-wide association studyMie Rizig, Sara Bandres-Ciga, Mary B Makarious, et al.
The Lancet. Neurology|August 18, 2023
Evaluation of the feasibility, diagnostic yield, and clinical utility of rapid genome sequencing in infantile epilepsy (Gene-STEPS): an international, multicentre, pilot cohort studyAlissa M D'Gama, Sarah Mulhern, Beth R Sheidley, et al.
The Lancet. Neurology|October 20, 2023
Hereditary transthyretin amyloid neuropathies: advances in pathophysiology, biomarkers, and treatmentDavid Adams, Yoshiki Sekijima, Isabel Conceição, et al.
The Lancet. Neurology|July 21, 2023
Soluble Nogo-Receptor-Fc decoy (AXER-204) in patients with chronic cervical spinal cord injury in the USA: a first-in-human and randomised clinical trialGeorge Maynard, Ramakrishnan Kannan, Jian Liu, et al.
The Lancet. Neurology|July 21, 2023
Insights into migraine attacks from neuroimagingRoberta Messina, Maria A Rocca, Peter J Goadsby, et al.
The Lancet. Neurology|July 21, 2023
Safety and efficacy of venglustat in GBA1-associated Parkinson's disease: an international, multicentre, double-blind, randomised, placebo-controlled, phase 2 trialNir Giladi, Roy N Alcalay, Gary Cutter, et al.
The Lancet. Neurology|June 23, 2023
Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised phase 1b/2a studyVolkan Granit, Michael Benatar, Metin Kurtoglu, et al.
Pageof 200